Health Care/Hospital

World First Test Breakthrough to Boost IVF Success Rates

MELBOURNE, Australia, May 28, 2019 /PRNewswire/ -- A new revolutionary non-invasive embryo screening testwill reduce miscarriages and the time it takes to achieve a healthy live birth for the one-in-six Australian couples affected by infertility. In a world-first scientific breakthrough, Austral...

2019-05-28 13:40 1616

IMI launches IMI Corporate Wellness amidst growing concerns for professionals' wellbeing.

HONG KONG, May 28, 2019 /PRNewswire/ -- Integrated Medicine Institute (IMI), Hong Kong's largest natural and integrated medicine clinic, today announced the official launch of its corporate wellness arm. Already at work in global organizations with a presence inHong Kong, IMI Corporate Wellness s...

2019-05-28 09:15 3483

The largest Traditional Chinese Medicine (TCM) player in South East Asia (SEA), Eu Yan Sang, joins BookDoc as a new Activ Reward Partner

SINGAPORE, May 28, 2019 /PRNewswire/ -- Eu Yan Sang, the largest Traditional Chinese Medicine (TCM) player inSouth East Asia (SEA) has joined BookDoc as a new Activ Reward Partner. This partnership promises more benefits for users in Singapore and 4 other countries which BookDoc operates in. Users...

2019-05-28 07:00 5386

Nanjing YiGenCloud Institute aims to speed up the process of China's precision medicine with "intelligence"

NANJING, China, May 27, 2019 /PRNewswire/ -- Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company inChina, described the blueprint of their China's precision medicine at the Nature conference: Genome Variation in Precision Medicine 2019he...

2019-05-27 20:25 2289

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

NESS ZIONA, Israel, May 27, 2019 /PRNewswire/ -- Ori Yehudai: "I took a company worth$3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants...

2019-05-27 20:05 2551

imSure Conducted Voluntary Health Insurance Scheme (VHIS) and Insurance Purchase Behavioral Research

HONG KONG, May 27, 2019 /PRNewswire/ -- The Voluntary Health Insurance Scheme (VHIS) was launched in early April this year. imSure, an online insurance comparison platform, has recently commissioned the Consumer Search Group to engage approximately 1,000Hong Kong residents aged between 18 and 64 ...

2019-05-27 17:59 4239

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection"

HONG KONG, May 27, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Group"), the largest cardio-cerebral vascular ("CCV") drug manufacturer in China's prescription drug market, announced the "non-PVC solid-liquid double chamber bag for ...

2019-05-27 17:08 5062

CALECIM(R) forms a major partnership with Menarini Asia-Pacific to expand the presence of its stem cell skin care products in the region

SINGAPORE, May 27, 2019 /PRNewswire/ -- CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers...

2019-05-27 15:00 3516

CALECIM(R) partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the region

SINGAPORE, May 27, 2019 /PRNewswire/ -- CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers...

2019-05-27 09:00 4199

111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

SHANGHAI, May 24, 2019 /PRNewswire/ -- Following 111, Inc.'s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. OnMay 24, 111 and MSH, a world leader in the design and management of international healthcare solu...

2019-05-24 22:45 8413

Five Directors of Golden Meditech Voluntarily Resigned Due to Personal Reasons

New Members on Board, the Company's Major Shareholder Maintains Full Confidence in Future Business Development HONG KONG, May 24, 2019 /PRNewswire/ -- Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech" or the "Company", together with its subsidiaries, the "Group"), a l...

2019-05-24 21:50 14046

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

SHANGHAI, May 24, 2019 /PRNewswire/ -- With fast advances in the medical industry, onMay 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held inGuangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the ...

2019-05-24 19:00 4467

B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...

2019-05-24 14:00 2522

Menicon Announces Launch of Menicon Bloom Myopia Control Management System

- Launch Features Initial Introduction of Menicon Bloom Night, First and Only CE-approved Orthokeratology Contact Lens inEurope for Myopia Control - NAGOYA, Japan, May 24, 2019 /PRNewswire/ -- Menicon Co., Ltd. announced on May 24 the launch of the Menicon Bloom Myopia Control Management System, ...

2019-05-24 13:00 3806

Elekta Unity MR-linac Receives Regulatory Approval From Japanese Ministry of Health, Labour and Welfare

With the potential to transform how clinicians treat cancer, Japan enters a new era of precision radiation medicine with magnetic resonance radiation therapy TOKYO, May 24, 2019 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Unity magnetic resonance radiation therapy system ha...

2019-05-24 07:05 7424

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase1b/2a clinical trial Study met primary safety and tolerability endpoints and showed initial evidence of potential efficacy in seizure reduction Data encou...

2019-05-24 05:04 7435

/C O R R E C T I O N -- World Federation of Hemophilia/

In the news release, The World Federation of Hemophilia (WFH) welcomes Bayer AG to the WFH Humanitarian Aid Program, issued23-May-2019 by World Federation of Hemophilia over PRNewswire, we are advised by the company that the name 'Bayer AG' should have been 'Bayer'. The complete, corrected rel...

2019-05-24 04:02 2533

APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...

2019-05-23 20:00 2933

MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics

TOKYO, May 23, 2019 /PRNewswire/ -- MGI , a subsidiary of global genomics leader BGI Group, announced it will begin marketing a total solution for single cell RNA Sequencing as part of the 10x Genomics' Compatible Product Partner Program on MGI's MGISEQ and BGISEQ sequenci...

2019-05-23 19:02 2906

Cstone partner Agios Announces the Phase 3 ClarIDHy Trial of TIBSOVO (ivosidenib) Achieved its Primary Endpoint

SUZHOU, China, May 23, 2019 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("Cstone"; HKEX:2616), Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) ("Agios") announced that the global Phase 3 ClarIDHy trial of TIBSOVO (ivosidenib) in previously treated cholangiocarcinoma patients with an isocitr...

2019-05-23 18:36 3617
1 ... 796797798799800801802 ... 807